ANTEROGEN CO., LTD.

Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.

065660 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 서울특별시 금천구 디지털로 130, 405호(가산동, 남성플라자), 서울특별시
Website:: http://anterogen.com
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Anterogen Co., Ltd. is a biotechnology company specializing in the research, development, and commercialization of cell therapy products and orphan drugs. The company's core technology leverages adult stem cells, particularly adipose-derived stem cells (ASCs), to create treatments for various medical conditions. Established with a research institute in 2000, Anterogen was a pioneer in the commercialization of ASC-based therapies in its domestic market. Its product pipeline is developed through clinical trials and focuses on leveraging the immune-modulating effects of its proprietary stem cell technology. The company manages the full lifecycle of its products, from research to manufacturing and distribution.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for ANTEROGEN CO., LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ANTEROGEN CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ANTEROGEN CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Labocanna Spolka Akcyjna Cultivates and distributes medical marijuana and cannabinoid products for clinical and consumer use.	Poland	LCN
Labomar A CDMO developing custom supplements, medical devices & cosmetics for third-party clients.	Italy	LBM
Laboratorio Farmaceutico Erfo Full-service contract manufacturer of private label supplements and medical devices.	Italy	ERFO
Laboratorio Reig Jofre S.A. A pharmaceutical company making essential health products accessible in over 70 countries.	Spain	RJF
Laboratorios Farmaceuticos Rovi S.A. Integrated pharma firm developing prescription drugs and offering contract manufacturing services.	Spain	ROVI
Lavipharm S.A. Develops & distributes Rx/OTC medicines, supplements & cosmetics for key therapeutic areas.	Greece	LAVI
Lineage Cell Therapeutics Inc. Developing off-the-shelf cell therapies for neurological and ophthalmic conditions.	Israel	LCTX
Lipigon Pharmaceuticals AB Develops novel drugs for lipid metabolism disorders to reduce cardiovascular disease risk.	Sweden	LPGO
Lipum AB Develops first-in-class antibody treatments for chronic inflammatory diseases like arthritis.	Sweden	LIPUM
Lonza Group AG A leading CDMO for pharma, biotech & nutrition, providing end-to-end development & manufacturing.	Switzerland	LONN